Literature DB >> 12884074

Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit.

T J Kidd1, S C Bell, C Coulter.   

Abstract

In this study, a combination of recA-based PCR assays and 16S rDNA restriction fragment length polymorphism (RFLP) analysis was used to determine the genomovar diversity of clinical Burkholderia cepacia complex isolates. Twenty-eight isolates were prospectively collected from patients attending a large Australian adult cystic fibrosis (CF) unit, 22 isolates were referred from other Australian CF units and a further eight isolates originated from patients without CF. The 28 prospectively collected isolates were distributed amongst the following genomovars: Burkholderia cepacia genomovar I (28.6%), Burkholderia multivorans (21.4%), Burkholderia cepacia genomovar III (39.3%), Burkholderia vietnamiensis(3.6%) and Burkholderia ambifaria (7.1%). The results of this study highlight the usefulness of 16S rDNA RFLP typing for the identification of other Burkholderia spp. and non-fermenting gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884074     DOI: 10.1007/s10096-003-0949-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.

Authors:  D A Henry; E Mahenthiralingam; P Vandamme; T Coenye; D P Speert
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Infection control in cystic fibrosis: practical recommendations for the hospital, clinic, and social settings.

Authors:  L Saiman; N Macdonald; J L Burns; N Hoiby; D P Speert; D Weber
Journal:  Am J Infect Control       Date:  2000-10       Impact factor: 2.918

Review 3.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; C Roller
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.

Authors:  C Segonds; T Heulin; N Marty; G Chabanon
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

6.  DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.

Authors:  E Mahenthiralingam; J Bischof; S K Byrne; C Radomski; J E Davies; Y Av-Gay; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 7.  Lung transplantation in cystic fibrosis: consensus conference statement.

Authors:  J R Yankaskas; G B Mallory
Journal:  Chest       Date:  1998-01       Impact factor: 9.410

8.  Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.

Authors:  E Mahenthiralingam; M E Campbell; D A Henry; D P Speert
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

9.  Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland.

Authors:  D Crowley; M Daly; B Lucey; P Shine; J J Collins; B Cryan; J E Moore; P Murphy; G Buckley; S Fanning
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

10.  Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.

Authors:  David P Speert; Deborah Henry; Peter Vandamme; Mary Corey; Eshwar Mahenthiralingam
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  9 in total

1.  Identification of isolates within the Burkholderia cepacia complex by a multiplex recA and 16S rRNA gene real-time PCR assay.

Authors:  Jason D Pimentel; Sally M Dubedat; Evan L N Dodds; Richard A V Benn
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

2.  Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.

Authors:  S Campana; G Taccetti; N Ravenni; F Favari; L Cariani; A Sciacca; D Savoia; A Collura; E Fiscarelli; G De Intinis; M Busetti; A Cipolloni; A d'Aprile; E Provenzano; I Collebrusco; P Frontini; G Stassi; M Trancassini; D Tovagliari; A Lavitola; C J Doherty; T Coenye; J R W Govan; P Vandamme
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.

Authors:  Rebecca Reik; Theodore Spilker; John J Lipuma
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre.

Authors:  G Golini; G Cazzola; R Fontana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

Review 5.  Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.

Authors:  Christopher H Goss; Jane L Burns
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

6.  Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.

Authors:  Kay A Ramsay; Claire A Butler; Stuart Paynter; Robert S Ware; Timothy J Kidd; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

7.  Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis.

Authors:  Sylvain Brisse; Christophe Cordevant; Peter Vandamme; Philippe Bidet; Chawki Loukil; Gérard Chabanon; Marc Lange; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.

Authors:  Timothy J Kidd; Kay A Ramsay; Honghua Hu; Peter T P Bye; Mark R Elkins; Keith Grimwood; Colin Harbour; Guy B Marks; Michael D Nissen; Philip J Robinson; Barbara R Rose; Theo P Sloots; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

9.  Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center.

Authors:  Priscila Dentini; Fernando Augusto Lima Marson; Luciana Cardoso Bonadia; Carmen Sílvia Bertuzzo; Antônio Fernando Ribeiro; Carlos Emílio Levy; José Dirceu Ribeiro
Journal:  Med Microbiol Immunol       Date:  2017-09-30       Impact factor: 3.402

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.